Healthcare

Arieli Group and Bar-Ilan University’s Tech Transfer Office, BIRAD, Announce Partnership to Accelerate the Commercialization of Pharmaceutical Research

The partnership aims to advance pharmaceutical and life sciences ventures originating from BIRAD- Bar-Ilan University, turning laboratory discoveries into solutions...

AngioDynamics to Report Fiscal 2025 Third Quarter Financial Results on April 2, 2025 and Host Virtual Cardiovascular Investor Event

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in...

New Novartis Phase III data demonstrate meaningful efficacy and safety results of intrathecal onasemnogene abeparvovec in broad patient population with SMA

New Novartis Phase III data demonstrate meaningful efficacy and safety results of intrathecal onasemnogene abeparvovec in broad patient population with...

error: Content is protected !!